ArticleBMJ open2023

Rationale and Design of the Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion Trial (CAPITAL-RAPTOR).

Pietro Di Santo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.